Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Solubilizers
Parenteral
Topical
Thickeners and Stabilizers
Surfactant & Foaming Agents
Film Formers & Plasticizers
Emulsifying Agents
Rheology Modifiers
Taste Masking
Coating Systems & Additives
Co-Processed Excipients
Direct Compression
Fillers, Diluents & Binders
API Stability Enhancers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
38
PharmaCompass offers a list of Chlorhexidine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chlorhexidine manufacturer or Chlorhexidine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chlorhexidine manufacturer or Chlorhexidine supplier.
PharmaCompass also assists you with knowing the Chlorhexidine API Price utilized in the formulation of products. Chlorhexidine API Price is not always fixed or binding as the Chlorhexidine Price is obtained through a variety of data sources. The Chlorhexidine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Chlorhexidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlorhexidine, including repackagers and relabelers. The FDA regulates Chlorhexidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlorhexidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chlorhexidine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chlorhexidine supplier is an individual or a company that provides Chlorhexidine active pharmaceutical ingredient (API) or Chlorhexidine finished formulations upon request. The Chlorhexidine suppliers may include Chlorhexidine API manufacturers, exporters, distributors and traders.
click here to find a list of Chlorhexidine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chlorhexidine DMF (Drug Master File) is a document detailing the whole manufacturing process of Chlorhexidine active pharmaceutical ingredient (API) in detail. Different forms of Chlorhexidine DMFs exist exist since differing nations have different regulations, such as Chlorhexidine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chlorhexidine DMF submitted to regulatory agencies in the US is known as a USDMF. Chlorhexidine USDMF includes data on Chlorhexidine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chlorhexidine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chlorhexidine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Chlorhexidine Drug Master File in Japan (Chlorhexidine JDMF) empowers Chlorhexidine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Chlorhexidine JDMF during the approval evaluation for pharmaceutical products. At the time of Chlorhexidine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Chlorhexidine suppliers with JDMF on PharmaCompass.
A Chlorhexidine written confirmation (Chlorhexidine WC) is an official document issued by a regulatory agency to a Chlorhexidine manufacturer, verifying that the manufacturing facility of a Chlorhexidine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Chlorhexidine APIs or Chlorhexidine finished pharmaceutical products to another nation, regulatory agencies frequently require a Chlorhexidine WC (written confirmation) as part of the regulatory process.
click here to find a list of Chlorhexidine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chlorhexidine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chlorhexidine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chlorhexidine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chlorhexidine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chlorhexidine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chlorhexidine suppliers with NDC on PharmaCompass.
Chlorhexidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chlorhexidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chlorhexidine GMP manufacturer or Chlorhexidine GMP API supplier for your needs.
A Chlorhexidine CoA (Certificate of Analysis) is a formal document that attests to Chlorhexidine's compliance with Chlorhexidine specifications and serves as a tool for batch-level quality control.
Chlorhexidine CoA mostly includes findings from lab analyses of a specific batch. For each Chlorhexidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chlorhexidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Chlorhexidine EP), Chlorhexidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chlorhexidine USP).
